MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer

by Croce Kimiko, Riley Christopher, Stejskal Amy, Cooke Larry S, Qi Wenqing, Saldanha Jose W, Bearss David, Mahadevan Daruka
Published 2009-05-01